Clinical

Dataset Information

0

A randomized phase 2 study comparing different dose-approaches of induction treatment (first cycle) of regorafenib in metastatic colorectal cancer (mCRC) patients


ABSTRACT: Primary objectives: To evaluate the safety and tolerability of different dose-escalation approaches of regorafenib in mCRC patients. Primary endpoints: Percentage of patients with G3/G4 treatment-related AEs in each arm according to CTCAE v4.03 criteria.

DISEASE(S): Metastatic Colorectal Cancer,Cancer Colorectal Metastásico

PROVIDER: 2535505 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2220026 | ecrin-mdr-crc
| 2533818 | ecrin-mdr-crc
2022-07-04 | GSE207008 | GEO
| PRJNA764419 | ENA
2012-01-21 | E-GEOD-35247 | biostudies-arrayexpress
| PRJNA764681 | ENA
2012-01-21 | GSE35247 | GEO
2024-07-05 | GSE186599 | GEO
2022-10-08 | GSE198565 | GEO
2016-01-29 | GSE77362 | GEO